Literature DB >> 12394851

Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage.

Mahyar Nouri-Shirazi1, Elisabeth Guinet.   

Abstract

BACKGROUND: Rejection of allografts entails the direct and indirect cross-recognition of donor major histocompatibility complex molecules by recipient alloreactive T cells. The ability to manipulate the state of dendritic cell (DC) maturation in vitro has enabled us to induce tolerance specifically targeting the alloreactive T-cell compartment. In this study, the immunoregulatory effect of alloantigen presentation by ex vivo-generated donor and recipient DCs retained in immature stage was investigated.
METHODS: Dendritic cell were generated by culturing monocytes with granulocyte-macrophage colony-stimulating factor and interleukin-4. Ex vivo-generated tolerogenic DCs were characterized by flow cytometry and confocal microscopy. Recipient T-cell responses to donor or recipient DCs loaded with donor-derived apoptotic cells were assessed in a two-step culture system.
RESULTS: Dendritic cells maintained their phagocytic and endocytic activities, and had significantly reduced capacity to prime recipient T cells. Moreover, primary coculture of recipient T cells with donor tolerogenic DCs rendered alloantigen-specific T cells hyporesponsive to a subsequent challenge with donor immunogenic DCs as evidenced by decreased proliferation and cytokine secretion. Importantly, recipient tolerogenic DCs loaded with donor-derived apoptotic cells were able to cross-tolerize recipient T cells. This was revealed by alloantigen-specific T-cell hyporesponsiveness on restimulation with the recipient immunogenic DCs loaded with different tissue-derived apoptotic cells obtained from the same donor.
CONCLUSIONS: Dendritic cells retained in immature stage induce direct and most importantly indirect cross-tolerance of alloantigen-specific T cells. It may be likely that administration of donor and/or recipient DCs could be one means with which to promote tolerance induction in acute and chronic phases of organ transplant.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12394851     DOI: 10.1097/00007890-200210150-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.

Authors:  Mao-Meng Tiao; Lina Lu; Ran Tao; Lianfu Wang; John J Fung; Shiguang Qian
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

Review 2.  Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells.

Authors:  Adrian E Morelli; Adriana T Larregina
Journal:  Apoptosis       Date:  2010-09       Impact factor: 4.677

3.  Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.

Authors:  Huan Yang; Yong Zhang; Minghua Wu; Jing Li; Wenbin Zhou; Guiyuan Li; Xiaoling Li; Bo Xiao; Premkumar Christadoss
Journal:  Inflamm Res       Date:  2009-09-19       Impact factor: 4.575

4.  Rapid deletional peripheral CD8 T cell tolerance induced by allogeneic bone marrow: role of donor class II MHC and B cells.

Authors:  Thomas Fehr; Sophia Wang; Fabienne Haspot; Josef Kurtz; Peter Blaha; Timothy Hogan; Meredith Chittenden; Thomas Wekerle; Megan Sykes
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

5.  Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides.

Authors:  Ming-Qing Xu; Yu-Ping Suo; Jian-Ping Gong; Ming-Man Zhang; Lu-Nan Yan
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

6.  Vitamin C acts indirectly to modulate isotype switching in mouse B cells.

Authors:  Ami Woo; Jin-Hee Kim; Young-Joo Jeong; Hyung Gun Maeng; Yong-Taek Lee; Jae Seung Kang; Wang Jae Lee; Young-Il Hwang
Journal:  Anat Cell Biol       Date:  2010-03-31

7.  Dendritic cells in cord blood transplantation: a review.

Authors:  Marta Isabel Pereira; Artur Paiva
Journal:  Stem Cells Int       Date:  2011-06-16       Impact factor: 5.443

Review 8.  Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?

Authors:  Brett Phillips; Massimo Trucco; Nick Giannoukakis
Journal:  Clin Dev Immunol       Date:  2011-07-18

9.  Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine.

Authors:  Igor Popov; Mu Li; Xiufen Zheng; Hongtao San; Xusheng Zhang; Thomas E Ichim; Motohiko Suzuki; Biao Feng; Costin Vladau; Robert Zhong; Bertha Garcia; Gill Strejan; Robert D Inman; Wei-Ping Min
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 10.  Transplant tolerance: new insights and strategies for long-term allograft acceptance.

Authors:  Paulina Ruiz; Paula Maldonado; Yessia Hidalgo; Alejandra Gleisner; Daniela Sauma; Cinthia Silva; Juan Jose Saez; Sarah Nuñez; Mario Rosemblatt; Maria Rosa Bono
Journal:  Clin Dev Immunol       Date:  2013-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.